Artificial Retina Market by Analysis, Top Companies, New Technology, Demand and Opportunity Analysis
The artificial retina market is primarily driven by the increasing developments
associated with sub retinal implants for the treatment of retinitis pigmentosa
(RP). Sub retinal implants are placed behind the retina and have proven to be
safe and restore useful vision to a majority of patients who are blind because
of RP.
Artificial retina is an implant which consists of an array of
microelectrodes and is used for the individuals who are visually impaired due
to retinal diseases. The progress of artificial retina is to restore limited
vision that enables people to read during mobility and to recognize
individuals. Artificial retina has proved to be a breakthrough invention for
the medical device industry, as it has provided hope to a large number of
visually impaired patients globally.
The device is made up of carbon nanotube biomimetic film
with accessories such as a transmitter and a video processing unit. The global
artificial retina market witnessed its first major breakthrough in 2013 with
the approval of Argus II Retinal Prosthesis System, by the U.S. Food and Drug
Administration (USFDA). It is a first implant device used to treat patients
with RP. Various conditions such as age-related macular degeneration (AMD) and
RP, which influence many individuals around the world, destroy the
photodetector cells in the retina and make vision worsen over time.
Increase in the prevalence of visually impaired patients,
growing healthcare expenditure, rising government investment in R&D for
artificial retina, and rise in geriatric population are the key factors driving
the artificial retina market, globally. According to the World Health
Organization (WHO) Prevention of Blindness and Deafness Programme, around 285
million people are visually impaired worldwide, 39 million are blind and 246
million have low vision (severe or moderate visual impairment), and the top
causes of the blindness are cataracts, glaucoma and AMD.
North America is expected to lead the global artificial
retina market throughout the forecast period, followed by Europe. This is
mainly due to strong healthcare infrastructure and high expenditure in R&D
in these regions. The healthcare industry in North America is undergoing major
transformation following the implementation of various healthcare reforms.
Moreover, the region is home to over 10 million visually impaired population
seeking effective treatment.
Some of the key players operating in the artificial retina
industry include Nano Retina, Second Sight Medical Products, Inc., Optobionics,
Aetna Inc., Pixium Vision, Retina Implant AG and Bionic Vision Technologies Pty
Ltd.
MARKET SEGMENTATION
By Type of Retinal Implant
·
Epiretinal implants
·
Subretinal implants
By Disease Indication
·
Age-related macular degeneration (AMD)
·
Retinitis pigmentosa
By End User
·
Multi-specialty hospitals
·
Ophthalmic clinics
·
Research institutes
By Region
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
U.K.
o
France
o
Italy
o
Spain
o
Rest of Europe
·
Asia-Pacific
o
Japan
o
Australia
o
China
o
India
o
Rest of Asia-Pacific
·
Rest of the World
Comments
Post a Comment